Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 5,353-5,364 of 6,115
Drug study icon
CompletedEUCTR 2011-000986-10

A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, FLEXIBLE-DOSE, PARALLEL-GROUP STUDY OF LURASIDONE ADJUNCTIVE TO LITHIUM OR DIVALPROEX FOR THE PREVENTION OF RECURRENCE IN SUBJECTS WITH BIPOLAR I DISO...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.
Countries
Czechia, Hungary, Poland, ...
Sponsor
Sunovion Pharmaceuticals Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2010-020170-42

An open-label study evaluating the Pharmacokinetics and Tolerability of Lu AA21004 in connection with multiple oral dosing of Lu AA21004 in child and adolescent patients with a DSM-IV-TRTM diagnosi...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionDrug
Countries
Germany
Sponsor
H. Lundbeck A/S
Condition
Anxiety, Depression
Drug study icon
TerminatedEUCTR 2006-001317-15

BALANCE 2: Bipolarity:Antidepressant/Lamotrigine/ANtipsychotic Comparative Evaluation

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Bipolarity, Depression
Biological study icon
CompletedEUCTR 2016-002326-36

Effects of erythropoietin (EPO) on cognitive side-effects of electroconvulsive therapy (ECT) (EPO-T)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionBiological
Countries
Denmark
Sponsor
Region Hovedstadens psykiatriske hospital
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2012-003404-12

Pharmacokinetics and safety of agomelatine in children (from 7 to less than 12 years) and adolescents (from 12 to less than 18 years) with Depressive or Anxiety Disorder. An open-labelled, multice...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Estonia
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionDrug
Countries
Estonia, Finland, Hungary, ...
Sponsor
Institut de Recherches Internationales Servier
Condition
Anxiety, Depression
Drug study icon
TerminatedEUCTR 2017-003705-17

Prevention of neuropsychiatric adverse effects caused by dexamethasone: translational insights from a placebo-controlled trial with hydrocortisone.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study includes Depression among several conditions.

Schizophrenia, Depression, ...Drug
Countries
Netherlands
Sponsor
LUMC
Condition
Schizophrenia, Depression, ...
Drug study icon
CompletedEUCTR 2004-005078-22

Quetiapin: Zur Sicherheit, Verträglichkeit und zum Einfluss auf kognitive Funktionen bei Patienten/innen mit einer schizophrenen Psychose Quetiapine: safety and influence on cognitive functions i...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Depression among several conditions.

Schizophrenia, DepressionDrug
Countries
Germany
Sponsor
Medical School of Hannover
Condition
Schizophrenia, Depression
Drug study icon
TerminatedEUCTR 2014-002451-26

The effect of intranasal ketamine on suicidality in severely depressed and suicidal patients. Randomized, placebo-controlled study

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Finland
Why is this study shown?

This study includes Depression among several conditions.

Suicidality, DepressionDrug
Countries
Finland
Sponsor
Department of Psychiatry, Helsinki University Central Hospital
Condition
Suicidality, Depression
Drug study icon
CompletedEUCTR 2022-000034-42

The Estimated 12-Hour Serum Lithium Level Pilot Study

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
Denmark
Sponsor
Aarhus University Hospital - Psychiatry, Department of Affective Disorders
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2011-006228-19

The treatment of traumatized refugees with Setraline versus Venlafaxine - a randomized trial.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study includes Depression among several conditions.

PTSD, DepressionDrug
Countries
Denmark
Sponsor
Psykiatrisk Center Ballerup
Condition
PTSD, Depression
Drug study icon
Recruitment unclearEUCTR 2013-004903-37

A RANDOMIZED, 6-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLEXIBLE DOSE, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LURASIDONE IN CHILDREN AND ADOLESCENT SUBJECTS WITH BIPOLAR I DEPR...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
France, United Kingdom, Bulgaria, ...
Sponsor
SUNOVION PHARMACEUTICALS INC.
Condition
Bipolarity, Depression
Drug study icon
Recruitment unclearEUCTR 2007-000479-40

Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with Bipolarity: searching for the antidepressant and mood stabilising neurophysiology

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
Germany
Sponsor
Department of Psychiatry, RWTH Aachen
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.